SOD1 and amyotrophic lateral sclerosis: Matamala et al. [47] showed that miR-142-3p expression was upregulated and miR-1249-3p expression was downregulated in ALS patients compared to controls, and both miR-142-3p and miR-1249-3p were aberrantly expressed in the SOD1 (G93A) mouse model.